Medication Safety in Pregnancy

• Home
• What is EUROmediCAT?
• Data
• Research
• Publications and Presentations
• Publications
• Conference Abstracts
• Other
• Partners
• Useful Links
• Contact Information

Where Am I? -> Publications and Presentations -> Conference Abstracts
Direct link to this page: http://www.EUROmediCAT.eu/publicationsandpresentations/conferenceabstracts

Conference Abstracts 

 

Title: Gabapentinoids exposure in early pregnancy and risk of congenital anomalies: a ConcePTION European case-malformed control study

Conférences : 

• Congress of the French Society of Pharmacology (SFPT, Société Française de Pharmacologie et de Thérapeutique) : 11-13 june 2024
• 2024 ISPE annual meeting : 24-28 august

 

Authors : Anna-Belle Beau, Erika Cifuentes Castro, Sudip Karki, Marie Beslay, Justine Benevent, Marie-Claude Addor, Jorieke Bergman, Clara Cavero-Carbonell, Ester Garne, Miriam Gatt, Jonathan Hoareau, Elly Den Hond, Anna Latos-Bielenska, Nathalie Lelong, Mary O’Mahony, Amanda J Neville, Anna Pierini, Helen Dolk, Joan Morris, Maria Loane, Christine Damase-Michel

 

Title "Risk of congenital ocular anomaly in EUROmediCAT: Assessment of the Potential Risk of Taking Medications during Pregnancy in Europe".

Conferences:

• congrès 2024 de la Société Française de Pharmacologie et de Thérapeutique. Date: 11-13 juin
• 2024 ISPE annual meeting. Date 24-28 august

Authors:

EA Cifuentes-Castro , AB Beau , A Caillet , F Fremont , A Neville , E Ballardini, H Dolk , M Loane , E Garne ,

B Khoshnood , N Lelong , A Rissmann , M O’mahony , A Pierini , M Gatt , JV Kammen-Bergman , AL Bielenska ,
LJ Echevarría González De Gariba , C Cavero Carbonell , M Addor , D Tucker , S Jordan , E Den Hond , I Barisic ,
F Rouget , H Randrianaivo , J Hoareau , I Perthus , M Courtade-Saïdi , C Damase-Michel , C Dubucs

Title : Specific congenital anomalies associated with maternal Multiple Sclerosis: A ConcePTION European case-malformed control study

Conferences :

• Congress of the French Society of Pharmacology (SFPT, Société Française de Pharmacologie et de Thérapeutique) : 11-13 june 2024
• 2024 ISPE annual meeting : 24-28 august

Authors : Marie Beslay, Erika Cifuentes-Castro, Sudip Karki, Anna-Belle Beau, Justine Benevent, Marie-Claude Addor, Ingeborg Barisic, Jorieke Bergman, Clara Cavero-Carbonell, Ester Garne, Miriam Gatt, Jonathan Hoareau, Elly Den Hond, Anna Latos-Bielenska, Nathalie Lelong, Mary O’Mahony, Amanda J. Neville, Anna Pierini, Anke Rissmann, Joan Morris, Helen Dolk, Maria Loane, Christine Damase-Michel

 

Title: " Antiretroviral drug exposure in pregnancy and risk of congenital anomalies: a European case-malformed control study "

name and date of the conference: SFPT congress, 11-13/06/2024(https://www.congres-sfpt.fr/)

authors:  Laura Saint-Lary, Anna-Belle Beau, Agnès Sommet, Valériane Leroy, Maria Loane, Marie-Claude Addor, Clara Cavero-Carbonell, Hermien De Walle, Ester Garne, Babak Khoshnood, Anna Latos Bielenska, Vera Nelen, Amanda J Neville, Mary O’mahony, Isabelle Perthus, Anna Pierini, Hanitra Randrianaivo, Anke Rissmann, Florence Rouget, David Tucker, Helen Dolk, Christine Damase-Michel

  Title:  The occurrence of specific congenital anomalies associated with maternal Systemic Lupus Erythematosus: A ConcePTION  Case-malformed control study in EUROmediCAT

Conferences: Congress of the French Society of Pharmacology (SFPT, Société Française de Pharmacologie et de Thérapeutique) : 11-13 june 2024

                       2024 ISPE annual meeting : 24-28 august

 Authors:  

               Sudip Karki, Marie Beslay, Erika Cifuentes Castro, Anna-Belle Beau, Justine Benevent, Marie-Claude Addor, Ingeborg Barisic,  Dieuwke Broekstra, Clara Cavero-Carbonell, Ester Garne, Miriam Gatt, Jonathan Hoareau, Elly Den Hond, Anna Latos-Bielenska,   Nathalie Lelong, Mary O’Mahony, Anna Pierini, Anke Rissmann, Helen Dolk, Maria Loane, Joan Morris, Christine Damase-Michel

  

ICPE conference

A European case-malformed control study assessing maternal exposure to antidepressants in the first trimester of pregnancy and risk of congenital anomalies: A contribution from the ConcePTION project.

 

 

European Conference, Poznan 2015 

 

 

European Conference "Safety of Medication Use in Pregnancy"      2-4 February 2015, Poznan, Poland [Abstract Book]  [Programme]

 

Opening Session	Mr Geoff Adams-Spink "Important of pharmacovigilance: lessons from the Thalidomide      tragedy" Prof Lolkje de Jong-van den Berg "EUROmediCAT: working towards an European      Reproductive Pharmacovigilance System
Introduction Session	Dr Maria Loane "The EUROmediCAT Database"
Session 1: Antidiabetics  in Pregnancy	Dr Rachel Charlton "Use of healthcare databases for studying drugs in pregnancy - the      example of antidiabetic drugs: EUROmediCAT results" Dr Hao Wang "Risk of congenital anomalies after exposure to insulin analogs compared      with human insulin in diabetic women: EUROmediCAT results"
Panel Discussion	Dr Belma Malanda - comments in relation to session 1a; Dr Belma Malanda - comments in relation to session 1b Dr Margery Morgan - comments in relation to session 1 Prof Gerard Visser - comments in relation to session 1 Prof Ewa Wender-Ozegowska - comments in relation to session 1
Session 2: Antiepileptics in pregnancy	Prof Lolkje de Jong-van den Berg "Antiepileptic drugs: use and safety: EUROmediCAT      results" Dr John Craig "EURAP and anti-epileptic drug safety monitoring"
Panel Discussion	Dr Renzo Guerrini - comments in relation to session 2 Prof Joanna Jedrzejczak - comments in relation to session 2 Dr Laura Yates - comments in relation to session 2
Session 3:  Antidepressants in pregnancy	Dr Rachel Charlton "The use of SSRIs in pregnancy: EUROmediCAT results" Dr Marian Bakker "Linking congenital anomaly registries with prescription data:      EUROmediCAT results Prof Helen Dolk "Risk of congenital anomalies in relation to SSRI use in pregnancy:      EUROmediCAT results
Panel Discussion	Dr Heli Malm - comments in relation to session 3 Dr Irene Petersen - comments in relation to session 3 Prof Janusz Rybakowski - comments in relation to session 3
Session 4: Antiasthmatics in pregnancy	Prof Kari Klungsoyr "Antiasthmatic drug use in pregnancy: EUROmediCAT results" Dr Ester Garne "Risk of congenital anomalies in relation to antiasthmatic use in pregnancy:      EUROmediCAT results
Panel Discussion	Prof Barbara Rogala - comments in relation to session 4
Session 5: Prevention of exposure to teratogenic drugs	Prof Marlene Sinclair "Implications of internet use by pregnant women and drug safety      recommendations: EUROmediCAT results Dr Christof Schaefer "The role of Teratogen Information Systems in Europe" Dr Francois Houyez "Pregnancy exposure to orphan medicinal products"
Panel Discussion	Prof Vincenzo Bettoli - comments in relation to session 5 Dr Ineke Crijns - comments in relation to session 5 Dr Laura Yates - comments in relation to session 5
Session 6: Signal detection	Dr Johannes Michiel Luteijn "Signal detection using congenital anomaly registry data" Dr Joanne Given "New signals from EUROmediCAT"
Panel Discussion	Dr David Prieto - comments in relation to session 6 Dr Jennita Reefhuis - comments in relation to session 6 Dr Kristina Star - comments in relation to session 6
Session 7: Recommendations for reproductive pharmacovigilance in Europe	Prof Helen Dolk "Building a sustainable reproductive pharmacovigilance system -      recommendations from EUROmediCAT Prof Corinne de Vries "Building a sustainable reproductive pharmacovigilance system -      the view from EMA
Panel Discussion	Mr Geoff Adams-Spink - comments in relation to session 7 Dr Kari Furu - comments in relation to session 7 Dr Christof Schaefer - comments in relation to session 7

EUROmediCAT is a project funded under the European Union's 7th Framework Programme
© EUROmediCAT, 2011